MedAvante: MedAvante Surpasses 630,000 Electronic Source (eSource) Clinical Trial Assessments

HAMILTON, N.J., Nov. 15, 2016 -- MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced significant advances in the deployment of the groundbreaking Virgil® Investigative Study Platform for global clinical trials as the source (eSource) data platform begins its third year in worldwide use.